Home Amines 5465-63-4
5465-63-4,MFCD00012853
Catalog No.:AA003GOY

5465-63-4 | 2-Bromobenzylamine, HCl

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$40.00   $28.00
- +
5g
>98.0%(T)
in stock  
$82.00   $57.00
- +
25g
>98.0%(T)
in stock  
$276.00   $193.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003GOY
Chemical Name:
2-Bromobenzylamine, HCl
CAS Number:
5465-63-4
Molecular Formula:
C7H9BrClN
Molecular Weight:
222.5101
MDL Number:
MFCD00012853
SMILES:
NCc1ccccc1Br.Cl
NSC Number:
29035
Properties
Properties
 
Form:
Solid  
MP:
227-230 °C  
Storage:
Inert atmosphere;Room Temperature;  

Computed Properties
 
Complexity:
85  
Covalently-Bonded Unit Count:
2  
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
1  

Downstream Synthesis Route
37803-02-4    5465-63-4   
4-(2-Bromobenzyl)-4H-dinaphth<2,1-c:1',2'-e>azepine 

[1]MonatsheftefurChemie,1996,vol.127,p.669-682

[1]Locationinpatent:experimentalpartKimura,Hidenori;Torikai,Kohei;Ueda,Ikuo[ChemicalandPharmaceuticalBulletin,2009,vol.57,#4,p.393-396]

[2]Baczko,Istvan;Liknes,David;Yang,Wei;Hamming,KevinC.;Searle,Gavin;Jaeger,Kristian;Husti,Zoltan;Juhasz,Viktor;Klausz,Gergely;Pap,Robert;Saghy,Laszlo;Varro,Andras;Dolinsky,Vernon;Wang,Shaohua;Rauniyar,Vivek;Hall,Dennis;Dyck,JasonR.B.;Light,PeterE.[BritishJournalofPharmacology,2014,vol.171,#1,p.92-106]

[3]CurrentPatentAssignee:UNIVERSITYOFALBERTA;CENTREFORDRUGRESEARCHANDDEVELOPMENT-WO2014/183221,2014,A1Locationinpatent:Paragraph00167

[4]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-US2005/250753,2005,A1Locationinpatent:Page/Pagecolumn62

[5]DeVita,RobertJ.;Bochis,Richard;Frontier,AlisonJ.;Kotliar,Andrew;Fisher,MichaelH.;Schoen,WilliamR.;Wyvratt,MatthewJ.;Cheng,Kang;Chan,WandaW.-S.;Butler,Bridget;Jacks,ThomasM.;Hickey,GerardJ.;Schleim,KlausD.;Leung,Kwan;Chen,Zhesheng;LeeChiu;Feeney,WilliamP.;Cunningham,PaulK.;Smith,RoyG.[JournalofMedicinalChemistry,1998,vol.41,#10,p.1716-1728]

[6]Shi,Qing;Ornstein,PaulL.;Briner,Karin;Richardson,TimothyI.;Arnold,MacklinB.;Backer,RyanT.;Buckmaster,JenniferL.;Canada,EmilyJ.;Doecke,ChristopherW.;Hertel,LarryW.;Honigschmidt,Nick;Hsiung,HansenM.;Husain,Saba;Kuklish,SteveL.;Martinelli,MichaelJ.;Mullaney,JeffreyT.;O'Brien,ThomasP.;Reinhard,MattR.;Rothhaar,Roger;Shah,Jikesh;Wu,Zhipei;Xie,Chaoyu;Zgombick,JohnM.;Fisher,MatthewJ.[BioorganicandMedicinalChemistryLetters,2006,vol.16,#9,p.2341-2346]

[7]CurrentPatentAssignee:MERCK&amp;COINC-US2002/193398,2002,A1

[8]CurrentPatentAssignee:MERCK&amp;COINC-US5438136,1995,A

[9]CurrentPatentAssignee:MERCK&amp;COINC-US5545735,1996,A

[10]CurrentPatentAssignee:MERCK&amp;COINC-US5583130,1996,A

[11]CurrentPatentAssignee:MERCK&amp;COINC-US5672596,1997,A

[12]CurrentPatentAssignee:MERCK&amp;COINC-US6211174,2001,B1

[13]CurrentPatentAssignee:EISAICOLTD-EP1394147,2004,A1Locationinpatent:Page146

[14]CurrentPatentAssignee:ELILILLY&amp;CO-US2004/82590,2004,A1Locationinpatent:Page/Pagecolumn52

[15]Cinelli,MarisA.;Reidl,CoryT.;Li,Huiying;Chreifi,Georges;Poulos,ThomasL.;Silverman,RichardB.[JournalofMedicinalChemistry,2020,vol.63,#9,p.4528-4554]

[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-EP1466904,2004,A1Locationinpatent:Page38

activecharcoal 
  5465-63-4    1976-04-1 

[1]CurrentPatentAssignee:GruenenthalPharmaGmbH&Co.Kommanditgesellschaft-US2002/198251,2002,A1

[1]Patent:US2008/171756,2008,A1.Locationinpatent:Page/Pagecolumn19

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5465-63-4 Molecular Formula|5465-63-4 MDL|5465-63-4 SMILES|5465-63-4 2-Bromobenzylamine, HCl |Organic_Building_Blocks